Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder-Reference-Cited by-同舟云学术

Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder

Published:2011-06 Issue:7 Volume:58 Page:1054-1063
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:

Author:

Sun Chih-Hao,Chang Yen-Hwa,Pan Chin-Chen

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2559.2011.03856.x/fullpdf

Reference22 articles.

1. Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway;Ching;Lab. Invest.,2010

2. The role of mTOR in the management of solid tumors: an overview;Strimpakos;Cancer Treat. Rev.,2009

3. Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies;Garcia;Mol. Cancer Ther.,2008

4. The Akt pathway in human breast cancer: a tissue-array-based analysis;Bose;Mod. Pathol.,2006

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives;International Journal of Molecular Sciences;2024-09-07

2. Asiaticoside enhances the effect of propofol on the invasion, ferroptosis and immune escape of bladder cancer;Drug Development Research;2024-08-19

3. Three-dimensional imaging of upper tract urothelial carcinoma improves diagnostic yield and accuracy;JCI Insight;2024-07-22

4. Genomic Profiling and Molecular Characterisation of Metastatic Urothelial Carcinoma;Medicina;2024-03-31

5. p-mTOR, p-ERK and PTEN Expression in Tumor Biopsies and Organoids as Predictive Biomarkers for Patients with HPV Negative Head and Neck Cancer;Head and Neck Pathology;2023-07-24